To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Expert-managed portfolios tailored to your financial goals and risk appetite.
| Sector Funds | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | -2.94% | 0.94% | 22.81% | 17.57% | 17.88% | 9.97% | 21.83% | 22.73% | 16.69% | 13.33% | 16.57% |
| Category returns | -2.38% | 0.98% | 21.27% | 13.65% | 15.21% | 6.84% | 20.17% | 19.31% | 13.54% | 13.51% | N/A |
| Absolute returns | -2.94% | 0.94% | 22.81% | 17.57% | 17.88% | 20.99% | 80.92% | 127% | 116.45% | 249.5% | 6452.43% |
| Rank within category | 14/18 | 10/18 | 7/18 | 5/18 | 6/17 | 4/14 | 2/12 | 1/10 | 1/9 | 3/4 | N/A |
| Sector Funds | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Yearly returns | -14.02% | 2.06% | -9.89% | -0.49% | 65.84% | 20.15% | -6.02% | 38.24% | 42.22% | -3.5% | 19.41% |
| Q1 returns | -11.31% | 6.25% | -11.2% | 0.34% | -4.18% | -0.75% | -6.29% | -2.23% | 11.71% | -5.88% | -1.34% |
| Q2 returns | 1.67% | -8.92% | -2.61% | -9.1% | 27.68% | 18.2% | -9.75% | 18.64% | 4.22% | 5.21% | 18.53% |
| Q3 returns | 5.89% | -3.27% | 9.49% | -0.3% | 22.44% | 1.15% | 8.9% | 8.96% | 17.36% | -2.85% | 2.65% |
| Q4 returns | -9.95% | 9.01% | -4.84% | 9.42% | 10.71% | 1.25% | 2.05% | 9.37% | 4.09% | 0.31% | -0.53% |
0.50% on or before 15D, Nil after 15D
| Alpha | 0.192902 |
| Beta | 0.8936 |
| Sharpe Ratio | 0.353441 |
| Sortino Ratio | 0.829438 |
| R-Squared | 0.936 |
| Tracking Error | 1.0351 |
| Downside Risk | 14.5074 |
| Std. Deviation (Annualised) | 13.1101 |
| Sector Funds | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Exp. Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HDFC Pharma and Healthcare Fund - Regular Plan - Growth | -1.96% | 2.52% | 25.9% | 20.68% | 24.58% | 28.56% | N/A | N/A | 28.56% | 3,310.64 | 2.11 | 0.48 | Very High |
| SBI Healthcare Opportunities Fund - Regular Plan - IDCW Current | -2.94% | 0.94% | 22.81% | 17.57% | 17.88% | 21.83% | 16.69% | 13.33% | 16.57% | 5,796.42 | 2.00 | 0.36 | Very High |
| UTI Healthcare Fund - Regular Plan - IDCW | -3.22% | 0.56% | 22.69% | 15.06% | 14.67% | 21.82% | 14.25% | 13.44% | 14.94% | 1,429.84 | 2.22 | 0.34 | Very High |
| ICICI Prudential Healthcare Fund - Growth | -2.36% | -3.03% | 15.18% | 4.94% | 6.63% | 20.73% | 14.84% | N/A | 19.12% | 6,995.62 | 2.08 | 0.31 | Very High |
| Mirae Asset Healthcare Fund - Regular Plan - Growth | -1.37% | 1.47% | 20.72% | 15.43% | 17.4% | 20.65% | 13.73% | N/A | 19.98% | 3,555.18 | 2.04 | 0.31 | Very High |
| LIC MF Healthcare Fund - Regular Plan - Growth | -3.5% | 1.21% | 21.34% | 11.16% | 11.73% | 19.96% | 10.82% | N/A | 16.95% | 103.11 | 2.67 | 0.30 | Very High |
| DSP Healthcare Fund - Regular Plan - Growth | -2.14% | 1.63% | 24.18% | 11.37% | 14.62% | 19.62% | 14.09% | N/A | 21% | 3,835.28 | 2.05 | 0.30 | Very High |
| Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth | -2.75% | -0.03% | 18.69% | 12.76% | 14.62% | 18.88% | 12.49% | N/A | 19.07% | 1,102.73 | 2.29 | 0.30 | Very High |
| Quant Healthcare Fund - Regular Plan - Growth | -2.13% | 2.74% | 21.8% | 16.66% | 16.64% | 18.72% | N/A | N/A | 19.66% | 428.30 | 3.13 | 0.24 | Very High |
| ITI Pharma & Healthcare Fund - Regular Plan - Growth | -2.2% | 0.08% | 19.58% | 10.81% | 9.58% | 17.23% | N/A | N/A | 12.25% | 276.23 | 2.63 | 0.23 | Very High |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 12.33% |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 8.17% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | Domestic Equities | 4.91% |
| Acutaas Chemicals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.91% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.72% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.67% |
| Max Healthcare Institute Ltd. | Healthcare Services | Domestic Equities | 4.31% |
| TREPS | Cash & Cash Equivalents and Net Assets | 4.11% | |
| Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.96% |
| Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.90% |
| Aster DM Quality Care Ltd. | Healthcare Services | Domestic Equities | 3.52% |
| Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.99% |
| Anthem Biosciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.90% |
| Sudeep Pharma Ltd. | Chemicals & Petrochemicals | Domestic Equities | 2.84% |
| Fortis Healthcare Ltd. | Healthcare Services | Domestic Equities | 2.82% |
| Biocon Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.67% |
| Jupiter Life Line Hospitals Ltd. | Healthcare Services | Domestic Equities | 2.55% |
| Sai Life Sciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.52% |
| Concord Biotech Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.40% |
| Aether Industries Ltd. | Chemicals & Petrochemicals | Domestic Equities | 2.33% |
| Poly Medicure Ltd. | Healthcare Equipment & Supplies | Domestic Equities | 1.94% |
| Global Health Ltd. | Healthcare Services | Domestic Equities | 1.91% |
| Ajanta Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.86% |
| Krishna Institute of Medical Sciences Ltd | Healthcare Services | Domestic Equities | 1.73% |
| Cohance Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.73% |
| Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.67% |
| Dr. Lal Pathlabs Ltd. | Healthcare Services | Domestic Equities | 1.47% |
| Healthcare Global Enterprises Ltd. | Healthcare Services | Domestic Equities | 1.27% |
| Syngene International Ltd. | Healthcare Services | Domestic Equities | 1.24% |
| Nephrocare Health Services Ltd. | Healthcare Services | Domestic Equities | 1.18% |
| Rainbow Children's Medicare Ltd. | Healthcare Services | Domestic Equities | 0.73% |
| Abbott India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.35% |
| Gufic Biosciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.29% |
| 364 DAY T-BILL 19.11.26 | Treasury Bills | 0.05% | |
| Net Receivable / Payable | Cash & Cash Equivalents and Net Assets | -0.94% | |
| Total | 100.00% | ||
Mr. Desai has close to 6 years of work experience with over 3 years of experience in Indian capital markets. He has been associated with SBI Funds Management Private Limited from May 2008. Prior to join SBI Funds Management Pvt. Ltd. he was a lecturer in Electronics Department with D J Sanghvi College of Engineering, Mumbai.
Get personalized portfolio management services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
